Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2019-08-16 | MMSI | Merit Medical Systems Inc | Karras Nolan E. | Dir | S - Sale+OE | $36.46 | -4,000 | 14,000 | -22% | -$145,840 | |||||
| DM | 2019-08-16 | CERS | Cerus Corp | Anderson Timothy B | Dir | S - Sale+OE | $5.40 | -18,795 | 177,859 | -10% | -$101,475 | |||||
2019-08-16 | INFU | Infusystem Holdings, Inc | Sansone Christopher R. | Dir | P - Purchase | $4.96 | +16,300 | 301,105 | +6% | +$80,784 | ||||||
2019-08-16 | IART | Integra Lifesciences Holdings Corp | Murphy Raymond G. | Dir | S - Sale | $60.99 | -4,136 | 69,787 | -6% | -$252,246 | ||||||
| M | 2019-08-16 | INSP | Inspire Medical Systems, Inc. | Jain Mudit K. | Dir | S - Sale | $66.84 | -2,240 | 7,620 | -23% | -$149,722 | |||||
| D | 2019-08-19 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale+OE | $66.86 | -4,000 | 5,106 | -44% | -$267,426 | |||||
| D | 2019-08-19 | BAX | Baxter International Inc | Gavin James R III | Dir | S - Sale+OE | $87.63 | -7,950 | 36,912 | -18% | -$696,659 | |||||
| D | 2019-08-15 | MMSI | Merit Medical Systems Inc | Millner F. Ann | Dir | S - Sale+OE | $36.67 | -3,780 | 11,230 | -25% | -$138,616 | |||||
2019-08-15 | DXCM | Dexcom Inc | Sayer Kevin R | Pres, CEO, COB | S - Sale | $156.12 | -10,000 | 257,259 | -4% | -$1,561,167 | ||||||
| DM | 2019-08-15 | GNMK | Genmark Diagnostics, Inc. | Oboyle Kevin C | Dir | S - Sale+OE | $6.51 | -18,350 | 88,777 | -17% | -$119,459 | |||||
| DM | 2019-08-15 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $20.92 | -2,000 | 1,368 | -59% | -$41,840 | |||||
| D | 2019-08-16 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale+OE | $49.33 | -50,000 | 930,742 | -5% | -$2,466,505 | |||||
2019-08-15 | CSII | Cardiovascular Systems Inc | Rosenstein Alexander | GC, Corp. Sec. | S - Sale | $47.04 | -1,136 | 79,589 | -1% | -$53,439 | ||||||
2019-08-15 | CSII | Cardiovascular Systems Inc | Sedo Sandra | Chief Compliance Officer | S - Sale | $47.06 | -882 | 51,357 | -2% | -$41,507 | ||||||
2019-08-15 | PODD | Insulet Corp | Spears Michael P | SVP, RA, Compliance | S - Sale | $146.12 | -4,153 | 22,626 | -16% | -$606,836 | ||||||
| D | 2019-08-16 | SIBN | Si-Bone, Inc. | Reckling W Carlton | CMO, VP, Medical Affairs | S - Sale+OE | $20.00 | -300 | 9,896 | -3% | -$6,000 | |||||
| D | 2019-08-16 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale+OE | $20.00 | -300 | 18,854 | -2% | -$6,000 | |||||
2019-08-16 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | COB, Pres, CEO | S - Sale | $19.64 | -40,000 | 607,537 | -6% | -$785,740 | ||||||
| M | 2019-08-15 | SIBN | Si-Bone, Inc. | Yerby Scott A | CTO | S - Sale | $18.45 | -10,533 | 121,082 | -8% | -$194,382 | |||||
| D | 2019-08-15 | BSX | Boston Scientific Corp | Butcher Arthur C | SVP, Pres, Endoscopy | S - Sale+OE | $41.98 | -6,329 | 15,974 | -28% | -$265,680 | |||||
| D | 2019-08-16 | SYK | Stryker Corp | Scannell Timothy J | Pres, COO | S - Sale+OE | $217.07 | -4,666 | 159,015 | -3% | -$1,012,872 | |||||
2019-08-16 | DRIO | Dariohealth Corp. | Shaked Yoav | Dir | P - Purchase | $0.45 | +12,888 | 404,779 | +3% | +$5,742 | ||||||
| D | 2019-08-15 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P | Pres, CEO | S - Sale+OE | $36.86 | -40,000 | 1,187,976 | -3% | -$1,474,480 | |||||
| D | 2019-08-14 | HRC | Hill-Rom Holdings, Inc. | Johnson Paul Sherwood | SVP, Pres - PSS Acute Care | S - Sale+OE | $104.26 | -6,470 | 4,564 | -59% | -$674,552 | |||||
| D | 2019-08-15 | TFX | Teleflex Inc | Hicks Cameron P | VP, Global HR | S - Sale+OE | $370.00 | -1,000 | 6,376 | -14% | -$370,000 | |||||
2019-08-16 | CTSO | Cytosorbents Corp | Bloch Kathleen P. | CFO | P - Purchase | $4.83 | +6,500 | 308,895 | +2% | +$31,395 | ||||||
2019-08-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.77 | +4,543 | 18,669,952 | 0% | +$3,480 | ||||||
| D | 2019-08-15 | RMD | Resmed Inc | Douglas Robert Andrew | Pres, COO ResMed Inc. | S - Sale+OE | $131.12 | -4,070 | 194,464 | -2% | -$533,658 | |||||
2019-08-15 | SYK | Stryker Corp | Datar Srikant M. | Dir | S - Sale | $215.00 | -350 | 14,486 | -2% | -$75,250 | ||||||
| DM | 2019-08-13 | LQDA | Liquidia Technologies Inc | Albury Timothy | SVP, Chief Accounting Officer | S - Sale+OE | $6.87 | -1,386 | 37,526 | -4% | -$9,524 | |||||
2019-08-14 | ELGX | Endologix Inc /de/ | Waller Gregory D | Dir | S - Sale | $6.61 | -715 | 29,922 | -2% | -$4,726 | ||||||
2019-08-14 | ELGX | Endologix Inc /de/ | Wilder Thomas | Dir | S - Sale | $6.61 | -1,369 | 27,864 | -5% | -$9,049 | ||||||
2019-08-15 | ICUI | Icu Medical Inc/de | Swinney Robert S | Dir | S - Sale | $165.18 | -2,078 | 18,470 | -10% | -$343,244 | ||||||
2019-08-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.76 | +31,000 | 18,665,409 | 0% | +$23,467 | ||||||
2019-08-13 | SILK | Silk Road Medical Inc | Warburg Pincus & Co. | 10% | S - Sale | $39.50 | -630,000 | 7,406,301 | -8% | -$24,885,000 | ||||||
2019-08-13 | SILK | Silk Road Medical Inc | Wp X Finance, L.P. | 10% | S - Sale | $39.50 | -630,000 | 7,406,301 | -8% | -$24,885,000 | ||||||
2019-08-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.72 | +15,500 | 18,634,409 | 0% | +$11,238 | ||||||
| D | 2019-08-14 | TFX | Teleflex Inc | Deren John | VP, Chief Accounting Officer | S - Sale+OE | $365.06 | -2,004 | 2,011 | -50% | -$731,590 | |||||
| D | 2019-08-12 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $132.35 | -6,651 | 314,664 | -2% | -$880,260 | |||||
2019-08-12 | SIBN | Si-Bone, Inc. | Skyline Venture Partners V LP | 10% | S - Sale | $18.25 | -400,000 | 4,019,985 | -9% | -$7,300,000 | ||||||
2019-08-12 | SIBN | Si-Bone, Inc. | Freund John Gordon | Dir, 10% | S - Sale | $18.25 | -400,000 | 4,019,985 | -9% | -$7,300,000 | ||||||
2019-08-12 | PEN | Penumbra Inc | Elsesser Adam | COB, CEO, Pres | S - Sale | $149.24 | -8,000 | 1,082,982 | -1% | -$1,193,947 | ||||||
2019-08-13 | BSX | Boston Scientific Corp | Sorenson John Bradley | SVP, Manuf, Sup Chn | S - Sale | $42.79 | -6,000 | 42,385 | -12% | -$256,757 | ||||||
| DM | 2019-08-12 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $21.34 | -3,800 | 1,368 | -74% | -$81,106 | |||||
| D | 2019-08-12 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $86.45 | -5,000 | 69,504 | -7% | -$432,250 | |||||
| D | 2019-08-12 | TCMD | Tactile Systems Technology Inc | Rishe Bryan | SVP, Sales | S - Sale+OE | $48.67 | -4,813 | 45,862 | -9% | -$234,261 | |||||
| D | 2019-08-13 | TNDM | Tandem Diabetes Care Inc | Cahill Edward L | Dir | S - Sale+OE | $63.03 | -1,417 | 3,982 | -26% | -$89,314 | |||||
| M | 2019-08-12 | VAPO | Vapotherm Inc | McQueen Michael | Officer | P - Purchase | $14.63 | +10,000 | 71,184 | +16% | +$146,330 | |||||
| D | 2019-08-12 | IRTC | Irhythm Technologies, Inc. | Garrett Matthew C. | CFO | S - Sale+OE | $76.83 | -27,569 | 20,867 | -57% | -$2,118,052 | |||||
2019-08-09 | CTSO | Cytosorbents Corp | Bloch Kathleen P. | CFO | P - Purchase | $5.52 | +1,500 | 302,395 | 0% | +$8,273 | ||||||
| D | 2019-08-12 | TNDM | Tandem Diabetes Care Inc | Hansen Brian B | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $62.97 | -15,000 | 2,991 | -83% | -$944,550 | |||||
2019-08-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.73 | +12,200 | 18,618,909 | 0% | +$8,967 | ||||||
| D | 2019-08-09 | LMAT | Lemaitre Vascular Inc | Thomas Michael H | Dir | S - Sale+OE | $32.10 | -15,000 | 0 | -100% | -$481,560 | |||||
2019-08-09 | INFU | Infusystem Holdings, Inc | Awm Investment Company, Inc. | 10% | P - Purchase | $4.74 | +16,650 | 2,000,000 | +1% | +$78,926 | ||||||
2019-08-08 | SILK | Silk Road Medical Inc | Warburg Pincus & Co. | 10% | S - Sale | $39.50 | -4,163,328 | 8,036,301 | -34% | -$164,451,456 | ||||||
2019-08-08 | SILK | Silk Road Medical Inc | Wp X Finance, L.P. | 10% | S - Sale | $39.50 | -4,163,328 | 8,036,301 | -34% | -$164,451,456 | ||||||
2019-08-08 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale | $51.13 | -2,106 | 86,278 | -2% | -$107,680 | ||||||
| DM | 2019-08-08 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $21.73 | -5,400 | 1,368 | -80% | -$117,354 | |||||
2019-08-08 | HAE | Haemonetics Corp | Gelbman Ronald G | Dir | S - Sale | $134.15 | -1,696 | 48,384 | -3% | -$227,518 | ||||||
| D | 2019-08-09 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale+OE | $133.23 | -475 | 2,789 | -15% | -$63,284 | |||||
| M | 2019-08-08 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, People, Culture, GC | S - Sale | $5.88 | -100,000 | 761,112 | -12% | -$587,500 | |||||
2019-08-08 | ANIK | Anika Therapeutics, Inc. | Thompson Jeffery S | Dir | S - Sale | $56.66 | -4,843 | 6,842 | -41% | -$274,404 | ||||||
| D | 2019-08-09 | BDX | Becton Dickinson & Co | Lim James C | EVP | S - Sale+OE | $253.31 | -23,879 | 21,097 | -53% | -$6,048,789 | |||||
2019-08-09 | BDX | Becton Dickinson & Co | Kaltenbach Patrick | EVP, Pres Life Sciences | S - Sale | $253.78 | -127 | 15,930 | -1% | -$32,230 | ||||||
2019-08-07 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $5.01 | -16,444 | 0 | -100% | -$82,324 | ||||||
| D | 2019-08-07 | HRC | Hill-Rom Holdings, Inc. | Rasin Deborah | SVP, GC | S - Sale+OE | $103.00 | -5,500 | 19,234 | -22% | -$566,500 | |||||
| D | 2019-08-08 | BDX | Becton Dickinson & Co | Kaltenbach Patrick | EVP, Pres Life Sciences | S - Sale+OE | $246.55 | -400 | 16,057 | -2% | -$98,620 | |||||
| D | 2019-08-08 | BDX | Becton Dickinson & Co | Goette Roland | EVP, Pres, EMEA | S - Sale+OE | $249.88 | -1,717 | 8,801 | -16% | -$429,044 | |||||
| D | 2019-08-08 | BDX | Becton Dickinson & Co | Lim James C | EVP | S - Sale+OE | $252.01 | -1,929 | 21,097 | -8% | -$486,127 | |||||
| D | 2019-08-06 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale+OE | $32.00 | -5,000 | 8,333 | -38% | -$160,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Kamdar Kim P. | Dir | P - Purchase | $4.00 | +12,500 | 27,148 | +85% | +$50,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Brister Mark | CTO | P - Purchase | $4.00 | +5,000 | 38,865 | +15% | +$20,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Macdonald Robert J | Chief Retail Officer | P - Purchase | $4.00 | +5,000 | 5,245 | >999% | +$20,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Hussainy Nooshin | VP of Finance | P - Purchase | $4.00 | +5,000 | 16,340 | +44% | +$20,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Rasdal Andrew P | Exec COB | P - Purchase | $4.00 | +12,500 | 77,892 | +19% | +$50,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Plovanic William J. | Pres, CFO | P - Purchase | $4.00 | +12,500 | 41,806 | +43% | +$50,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Vandenberg Amy | Chief Clinical, Reg Officer | P - Purchase | $4.00 | +2,500 | 11,764 | +27% | +$10,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Howe Lesley H | Dir | P - Purchase | $4.00 | +6,250 | 19,397 | +48% | +$25,000 | |||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Stevenson Sharon | Dir | P - Purchase | $4.00 | +7,500 | 106,809 | +8% | +$30,000 | |||||
2019-08-06 | SIBN | Si-Bone, Inc. | Yerby Scott A | CTO | S - Sale | $17.07 | -649 | 131,615 | 0% | -$11,078 | ||||||
2019-08-05 | GNMK | Genmark Diagnostics, Inc. | McNally James B. | SVP, Marketing, Bus. Dev. | S - Sale | $5.87 | -1,006 | 260,223 | 0% | -$5,905 | ||||||
2019-08-05 | GNMK | Genmark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | S - Sale | $5.87 | -711 | 206,207 | 0% | -$4,174 | ||||||
2019-08-05 | GNMK | Genmark Diagnostics, Inc. | Ek John Frederick | CFO | S - Sale | $5.87 | -1,890 | 174,648 | -1% | -$11,094 | ||||||
| D | 2019-08-06 | OBLN | Obalon Therapeutics Inc | Interwest Partners X LP | 10% | P - Purchase | $4.00 | +25,000 | 380,224 | +7% | +$100,000 | |||||
| DM | 2019-08-05 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $21.93 | -7,000 | 1,368 | -84% | -$153,510 | |||||
| D | 2019-08-07 | SYK | Stryker Corp | Golston Allan C. | Dir | S - Sale+OE | $209.84 | -3,399 | 9,027 | -27% | -$713,232 | |||||
| D | 2019-08-05 | ABMD | Abiomed Inc | Weber David M | COO | S - Sale+OE | $206.26 | -8,095 | 140,315 | -5% | -$1,669,693 | |||||
2019-08-07 | BDX | Becton Dickinson & Co | Fraser Claire | Dir | S - Sale | $243.26 | -1,429 | 21,544 | -6% | -$347,619 | ||||||
2019-08-06 | VAPO | Vapotherm Inc | Weatherman Elizabeth H | Dir | P - Purchase | $14.50 | +30,000 | 101,417 | +42% | +$435,000 | ||||||
2019-08-02 | TNDM | Tandem Diabetes Care Inc | Roeder Douglas A | Dir | S - Sale | $70.01 | -9,471 | 12,651 | -43% | -$663,076 | ||||||
2019-08-06 | AXNX | Axonics Modulation Technologies, Inc. | Cohen Raymond W | CEO | P - Purchase | $30.41 | +3,500 | 1,375,542 | 0% | +$106,439 | ||||||
| D | 2019-08-02 | MMSI | Merit Medical Systems Inc | Stillabower Michael E | Dir | S - Sale+OE | $40.05 | -40,750 | 107,868 | -27% | -$1,632,103 | |||||
2019-08-02 | NVCR | Novocure Ltd | Shah Pritesh | Chief Commercial Officer | S - Sale | $85.23 | -1,813 | 76,976 | -2% | -$154,522 | ||||||
| D | 2019-08-05 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Chief Legal, Compliance | S - Sale+OE | $62.56 | -2,000 | 3,511 | -36% | -$125,120 | |||||
| D | 2019-08-02 | TNDM | Tandem Diabetes Care Inc | Hansen Brian B | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $70.01 | -5,000 | 2,991 | -63% | -$350,050 | |||||
2019-08-05 | TNDM | Tandem Diabetes Care Inc | Greene Howard E Jr | Dir | S - Sale | $61.50 | -10,000 | 30,000 | -25% | -$615,038 | ||||||
| D | 2019-08-05 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $128.56 | -4,367 | 117,883 | -4% | -$561,422 | |||||
| M | 2019-08-01 | IRMD | Iradimed Corp | Waldman Louis S. | Controller | S - Sale | $22.71 | -25,000 | 2,005 | -93% | -$567,869 | |||||
2019-08-01 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $68.02 | -10,000 | 397,849 | -2% | -$680,151 | ||||||
2019-08-01 | SRDX | Surmodics Inc | Stich Joseph J. | VP, GM, IVD | S - Sale | $47.00 | -2,000 | 50,637 | -4% | -$94,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |